Watchman FLX pro laac device
Ended Awarded Last action
- Contract number
- SPE2D626F54U9
- Awardee
-
Boston Scientific Corp UEI YWDHHW3DLNQ1
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $19,576
Award facts
- Contract value 100% obligated
- $19,576.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Marlborough, MA 01752, USA
Award details come from SAM.gov/FPDS.
About this award
Boston Scientific Corp has been awarded a delivery order valued at $19,576 for the provision of WATCHMAN FLX PRO left atrial appendage closure devices under a fixed-price contract with economic price adjustment provisions. The delivery order, issued on December 23, 2025, with completion scheduled for December 31, 2025, will be performed in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters. This award was issued without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. The contract is funded through the Defense Health Agency's Medical Supply Chain division, reflecting the federal government's reliance on Boston Scientific as a critical supplier of specialized cardiovascular medical devices to military healthcare facilities and Veterans Affairs medical centers.
This delivery order is issued against Boston Scientific's broader Blanket Purchase Agreement with the Defense Health Agency, a $750,000 indefinite delivery vehicle established on March 31, 2025, with a completion date of March 30, 2030. The BPA positions Boston Scientific as a primary supplier for advanced medical devices across multiple therapeutic areas, including cardiovascular, interventional, diagnostic, and neuromodulation technologies. WATCHMAN devices are minimally invasive left atrial appendage closure systems used to reduce stroke risk in patients with atrial fibrillation, representing a critical component of Boston Scientific's cardiac device portfolio supplied to federal healthcare agencies. The delivery order structure enables the Defense Health Agency to rapidly procure specialized medical devices while maintaining supply chain continuity for advanced treatment modalities across the defense and veterans healthcare enterprises.
Quick answers
Who was awarded contract SPE2D626F54U9?
SPE2D626F54U9 was awarded to Boston Scientific Corp by Medical Supply Chain (Troop Support) on December 23, 2025.
How much is contract SPE2D626F54U9 worth?
The government has obligated $19,576 on SPE2D626F54U9.
Is contract SPE2D626F54U9 an order under another contract?
Yes. SPE2D626F54U9 is a delivery order under SPE2DE21D7020, an indefinite delivery contract.
Was contract SPE2D626F54U9 competed?
The extent of competition for SPE2D626F54U9 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award